Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration.
D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000336:Aerosols; D000420:Albuterol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001249:Asthma / Q000188:drug therapy*; D004809:Ephedrine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D000860:Hypoxia / Q000139:chemically induced; D007545:Isoproterenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013726:Terbutaline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D004809:Ephedrine; D007545:Isoproterenol; D013726:Terbutaline; D000420:Albuterol